The MetroHealth System is a clinical research site located in Cleveland, Ohio, United States 44109.
Crixeo Clinical Trials Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
The MetroHealth System has participated in 27 clinical trials with 11 currently active.
Therapeutic areas: ACE Inhibitor Induced Angioedema, Gastroesophageal Reflux Disease (GERD), Reflux, Gastroesophageal.
Sponsors: Shire, EndoStim Inc., University of Alabama at Birmingham.
Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The MetroHealth System has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The MetroHealth System has 27 clinical trials on record, with 11 currently active. Their work covers ACE Inhibitor Induced Angioedema, Gastroesophageal Reflux Disease (GERD), Reflux, Gastroesophageal.
The MetroHealth System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.